Health & Fitness
Health and Fitness
Health and Fitness 
Wed, March 9, 2011
Tue, March 8, 2011
The Law Office of Joseph Klein is Investigating Possible Breaches of Fiduciary Duty by the Board of TomoTherapy Incorporated in
NEW YORK--([ BUSINESS WIRE ])--The Law Office of Joseph Klein is investigating the Board of Directors of TomoTherapy Incorporated (Nasdaq: TOMO) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the company to Accuray Incorporated (Nasdaq: ARAY). Under the terms of the proposed transaction, TomoTherapy stockholders will receive $3.15 in cash and 0.1648 shares of Accuray stock per share of TomoTherapy. Based on prior closing price of Accuray stock, the transaction values TomoTherapy stock at $4.80 per share for a total transaction value of approximately $277 million.
The investigation concerns whether the TomoTherapy Board of Directors breached their fiduciary duties to TomoTherapy stockholders by failing to adequately shop the Company before entering into this transaction and whether Accuray is underpaying for TomoTherapy shares. Yahoo! Finance reports one analyst that set a price target of $5.00 per share for TomoTherapy stock.
If you own common stock in TomoTherapy and wish to obtain additional information, please contact Joseph Klein, Esq. directly, via email at [ jk@jkleinlawfirm.com ], by telephone at 718-947-0005, Toll Free: 877-STOK-180, or visit [ http://www.jkleinlawfirm.com/tomotherapy-tomo.html ].
Joseph Klein, Esq. is an experienced attorney and has also practiced as a Certified Public Accountant. Mr. Klein represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.